339 related articles for article (PubMed ID: 23178646)
21. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
22. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
[TBL] [Abstract][Full Text] [Related]
23. Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia.
Bah A; Pasricha SR; Jallow MW; Sise EA; Wegmuller R; Armitage AE; Drakesmith H; Moore SE; Prentice AM
J Nutr; 2017 Jun; 147(6):1131-1137. PubMed ID: 28424258
[No Abstract] [Full Text] [Related]
24. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
[TBL] [Abstract][Full Text] [Related]
25. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
26. The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis.
Uijterschout L; Swinkels DW; Akkermans MD; Zandstra T; Nuijsink M; Hendriks D; Hudig C; Tjalsma H; Vos R; van Goudoever JB; Brus F
J Cyst Fibros; 2014 Dec; 13(6):639-44. PubMed ID: 24735882
[TBL] [Abstract][Full Text] [Related]
27. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
28. Serum prohepcidin concentrations in rheumatoid arthritis.
Jayaranee S; Sthaneshwar P; Sokkalingam S
Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
[TBL] [Abstract][Full Text] [Related]
29. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
Ebner N; Jankowska EA; Ponikowski P; Lainscak M; Elsner S; Sliziuk V; Steinbeck L; Kube J; Bekfani T; Scherbakov N; Valentova M; Sandek A; Doehner W; Springer J; Anker SD; von Haehling S
Int J Cardiol; 2016 Feb; 205():6-12. PubMed ID: 26705670
[TBL] [Abstract][Full Text] [Related]
30. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.
Tessitore N; Girelli D; Campostrini N; Bedogna V; Pietro Solero G; Castagna A; Melilli E; Mantovani W; De Matteis G; Olivieri O; Poli A; Lupo A
Nephrol Dial Transplant; 2010 Dec; 25(12):3996-4002. PubMed ID: 20538788
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of transferrin saturation in heart failure patients.
Campodonico J; Nicoli F; Motta I; Migone De Amicis M; Bonomi A; Cappellini M; Agostoni P
Eur J Prev Cardiol; 2021 Dec; 28(15):1639-1646. PubMed ID: 33619543
[TBL] [Abstract][Full Text] [Related]
32. Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency.
Tarancon-Diez L; Genebat M; Roman-Enry M; Vázquez-Alejo E; Espinar-Buitrago MS; Leal M; Muñoz-Fernandez MÁ
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432426
[TBL] [Abstract][Full Text] [Related]
33. Iron deficiency and red cell indices in patients with heart failure.
Tkaczyszyn M; Comín-Colet J; Voors AA; van Veldhuisen DJ; Enjuanes C; Moliner-Borja P; Rozentryt P; Poloński L; Banasiak W; Ponikowski P; van der Meer P; Jankowska EA
Eur J Heart Fail; 2018 Jan; 20(1):114-122. PubMed ID: 28386910
[TBL] [Abstract][Full Text] [Related]
34. Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.
Aksan A; Wohlrath M; Iqbal TH; Dignass A; Stein J
J Crohns Colitis; 2020 Mar; 14(3):316-322. PubMed ID: 31665264
[TBL] [Abstract][Full Text] [Related]
35. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
36. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
37. Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab.
Loveikyte R; Bourgonje AR; van der Reijden JJ; Bulthuis MLC; Hawinkels LJAC; Visschedijk MC; Festen EAM; van Dullemen HM; Weersma RK; van Goor H; van der Meulen-de Jong AE; Dijkstra G
Inflamm Bowel Dis; 2023 Aug; 29(8):1272-1284. PubMed ID: 36748574
[TBL] [Abstract][Full Text] [Related]
38. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
[TBL] [Abstract][Full Text] [Related]
39. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
